Loading…

The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37

The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was great...

Full description

Saved in:
Bibliographic Details
Published in:Journal of antimicrobial chemotherapy 1991-12, Vol.28 (6), p.843-853
Main Authors: Bojar, Richard A., Holland, Keith T., Cunliffe, William J.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3
cites
container_end_page 853
container_issue 6
container_start_page 843
container_title Journal of antimicrobial chemotherapy
container_volume 28
creator Bojar, Richard A.
Holland, Keith T.
Cunliffe, William J.
description The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.
doi_str_mv 10.1093/jac/28.6.843
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72709285</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>72709285</sourcerecordid><originalsourceid>FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</originalsourceid><addsrcrecordid>eNqFkE1rVDEUQIModVrduRWyEFd903znZSnVsUJLi1Qo3YQk7wZT38c0eU_UX2-GGepS7uIuzuFyOQi9oWRNieFnDy6csXat1q3gz9CKCkUaRgx9jlaEE9loIflLdFzKAyFESdUeoSOqmaLKrND97XfAaWx-pjlP2I1zGlLIk0-uxxAjhLngKWL3B3qXAnYhdXjZTiO-ydM2TWPyLsyQ0zJUNkLBZc4uVcz1K_Qiur7A68M-Qd82n27PL5rL689fzj9cNoEZMzeikx3xoHfjhQycOJD1b9pF7hkJQUXRgRFREqqI9Eo5BbrzlJoYfQf8BL3f393m6XGBMtshlQB970aYlmI108SwVv5XpIpSYchOPN2LtUQpGaLd5jS4_NtSYnfNbW1uWWuVrc2r_vZwd_EDdP_kfeTK3x24K8H1MbsxpPKkSdoKKVnVmr2Wygy_nrDLP6zSXEt7cXdvr242H-80_Wo3_C_MB5l0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16114905</pqid></control><display><type>article</type><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><source>Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025</source><creator>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</creator><creatorcontrib>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</creatorcontrib><description>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</description><identifier>ISSN: 0305-7453</identifier><identifier>EISSN: 1460-2091</identifier><identifier>DOI: 10.1093/jac/28.6.843</identifier><identifier>PMID: 1726169</identifier><identifier>CODEN: JACHDX</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial Proteins - biosynthesis ; Biological and medical sciences ; Culture Media ; Dermatologic Agents - metabolism ; Dermatologic Agents - pharmacology ; Dicarboxylic Acids - metabolism ; Dicarboxylic Acids - pharmacology ; DNA, Bacterial - biosynthesis ; Hydrogen-Ion Concentration ; Medical sciences ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Propionibacterium acnes - drug effects ; Propionibacterium acnes - growth &amp; development ; Propionibacterium acnes - metabolism ; RNA, Bacterial - biosynthesis ; Species Specificity ; Temperature</subject><ispartof>Journal of antimicrobial chemotherapy, 1991-12, Vol.28 (6), p.843-853</ispartof><rights>1992 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=5184552$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1726169$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bojar, Richard A.</creatorcontrib><creatorcontrib>Holland, Keith T.</creatorcontrib><creatorcontrib>Cunliffe, William J.</creatorcontrib><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><title>Journal of antimicrobial chemotherapy</title><addtitle>J Antimicrob Chemother</addtitle><description>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</description><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial Proteins - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Culture Media</subject><subject>Dermatologic Agents - metabolism</subject><subject>Dermatologic Agents - pharmacology</subject><subject>Dicarboxylic Acids - metabolism</subject><subject>Dicarboxylic Acids - pharmacology</subject><subject>DNA, Bacterial - biosynthesis</subject><subject>Hydrogen-Ion Concentration</subject><subject>Medical sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Propionibacterium acnes - drug effects</subject><subject>Propionibacterium acnes - growth &amp; development</subject><subject>Propionibacterium acnes - metabolism</subject><subject>RNA, Bacterial - biosynthesis</subject><subject>Species Specificity</subject><subject>Temperature</subject><issn>0305-7453</issn><issn>1460-2091</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1991</creationdate><recordtype>article</recordtype><recordid>eNqFkE1rVDEUQIModVrduRWyEFd903znZSnVsUJLi1Qo3YQk7wZT38c0eU_UX2-GGepS7uIuzuFyOQi9oWRNieFnDy6csXat1q3gz9CKCkUaRgx9jlaEE9loIflLdFzKAyFESdUeoSOqmaLKrND97XfAaWx-pjlP2I1zGlLIk0-uxxAjhLngKWL3B3qXAnYhdXjZTiO-ydM2TWPyLsyQ0zJUNkLBZc4uVcz1K_Qiur7A68M-Qd82n27PL5rL689fzj9cNoEZMzeikx3xoHfjhQycOJD1b9pF7hkJQUXRgRFREqqI9Eo5BbrzlJoYfQf8BL3f393m6XGBMtshlQB970aYlmI108SwVv5XpIpSYchOPN2LtUQpGaLd5jS4_NtSYnfNbW1uWWuVrc2r_vZwd_EDdP_kfeTK3x24K8H1MbsxpPKkSdoKKVnVmr2Wygy_nrDLP6zSXEt7cXdvr242H-80_Wo3_C_MB5l0</recordid><startdate>199112</startdate><enddate>199112</enddate><creator>Bojar, Richard A.</creator><creator>Holland, Keith T.</creator><creator>Cunliffe, William J.</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>199112</creationdate><title>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</title><author>Bojar, Richard A. ; Holland, Keith T. ; Cunliffe, William J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1991</creationdate><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial Proteins - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Culture Media</topic><topic>Dermatologic Agents - metabolism</topic><topic>Dermatologic Agents - pharmacology</topic><topic>Dicarboxylic Acids - metabolism</topic><topic>Dicarboxylic Acids - pharmacology</topic><topic>DNA, Bacterial - biosynthesis</topic><topic>Hydrogen-Ion Concentration</topic><topic>Medical sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Propionibacterium acnes - drug effects</topic><topic>Propionibacterium acnes - growth &amp; development</topic><topic>Propionibacterium acnes - metabolism</topic><topic>RNA, Bacterial - biosynthesis</topic><topic>Species Specificity</topic><topic>Temperature</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bojar, Richard A.</creatorcontrib><creatorcontrib>Holland, Keith T.</creatorcontrib><creatorcontrib>Cunliffe, William J.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of antimicrobial chemotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bojar, Richard A.</au><au>Holland, Keith T.</au><au>Cunliffe, William J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37</atitle><jtitle>Journal of antimicrobial chemotherapy</jtitle><addtitle>J Antimicrob Chemother</addtitle><date>1991-12</date><risdate>1991</risdate><volume>28</volume><issue>6</issue><spage>843</spage><epage>853</epage><pages>843-853</pages><issn>0305-7453</issn><eissn>1460-2091</eissn><coden>JACHDX</coden><abstract>The in-vitro antimicrobial activity of azelaic acid, a new topical acne treatment, upon Propionibacterium acnes strain P37 was studied. In phosphate buffer at pH 6.0 500 mM azelaic acid had bactericidal activity whilst the addition of nutrients reduced susceptibility. Bactericidal activity was greatly enhanced by reducing the pH to 5.6. In a simple denned medium growth was inhibited by 100μM azelaic acid. The accumulation of 14C azelaic acid was pH and temperature dependent with maximum uptake occurring at pH 4.6, 30°C. Valinomycin, nigericin and CCCP (membrane-active inhibitors of energy transduction) inhibited uptake and azelaic acid was not accumulated by non-viable cells. The degradation of azelaic acid was repressed by glucose, and acetic acid was the major end-product of azelaic acid degradation in glucose depleted media. The incorporation of radiolabelled precursors into protein, DNA and RNA were inhibited in a dose dependent manner, and 50% inhibition occurred at 313, 3639 and 9226 μM respectively. The synthesis of proteins was shown to be significantly more sensitive to the action of azelaic acid than both RNA and DNA synthesis.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>1726169</pmid><doi>10.1093/jac/28.6.843</doi><tpages>11</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0305-7453
ispartof Journal of antimicrobial chemotherapy, 1991-12, Vol.28 (6), p.843-853
issn 0305-7453
1460-2091
language eng
recordid cdi_proquest_miscellaneous_72709285
source Oxford University Press:Jisc Collections:Oxford Journal Archive: Access period 2024-2025
subjects Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial Proteins - biosynthesis
Biological and medical sciences
Culture Media
Dermatologic Agents - metabolism
Dermatologic Agents - pharmacology
Dicarboxylic Acids - metabolism
Dicarboxylic Acids - pharmacology
DNA, Bacterial - biosynthesis
Hydrogen-Ion Concentration
Medical sciences
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Propionibacterium acnes - drug effects
Propionibacterium acnes - growth & development
Propionibacterium acnes - metabolism
RNA, Bacterial - biosynthesis
Species Specificity
Temperature
title The in-vitro antimicrobial effects of azelaic acid upon Propionibacterium acnes strain P37
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T02%3A09%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20in-vitro%20antimicrobial%20effects%20of%20azelaic%20acid%20upon%20Propionibacterium%20acnes%20strain%20P37&rft.jtitle=Journal%20of%20antimicrobial%20chemotherapy&rft.au=Bojar,%20Richard%20A.&rft.date=1991-12&rft.volume=28&rft.issue=6&rft.spage=843&rft.epage=853&rft.pages=843-853&rft.issn=0305-7453&rft.eissn=1460-2091&rft.coden=JACHDX&rft_id=info:doi/10.1093/jac/28.6.843&rft_dat=%3Cproquest_cross%3E72709285%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c299t-4d5d0be7e7e7b45c30ae53051df3b20cc6f4de94f501605b66a6e7db119ffbde3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=16114905&rft_id=info:pmid/1726169&rfr_iscdi=true